JAVIER
ESCANED BARBOSA
Profesor asociado de Ciencias de la Salud
ANDRÉS
ÍÑIGUEZ ROMO
Ikertzailea 2007-(e)ra arte
ANDRÉS ÍÑIGUEZ ROMO-rekin lankidetzan egindako argitalpenak (14)
2023
-
Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)
American Journal of Cardiology, Vol. 190, pp. 32-40
2022
-
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design
American Heart Journal, Vol. 246, pp. 32-43
-
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study
European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316
-
Impact of Diabetes on 10-Year Outcomes Following ST-Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial
Journal of the American Heart Association, Vol. 11, Núm. 23
-
Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial
JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1965-1973
2021
-
Percutaneous and surgical aortic valve replacement. Impact of volume and type of center on results
REC: Interventional Cardiology, Vol. 3, Núm. 2, pp. 103-111
-
Reemplazo valvular aórtico percutáneo y quirúrgico.: Influencia del volumen y del tipo de centro tratante en los resultados
REC: Interventional Cardiology, Vol. 3, Núm. 2, pp. 103-111
2019
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: Twoyear follow-up of the SYNTAX II study
EuroIntervention, Vol. 15, Núm. 3, pp. E244-A252
-
Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial
Catheterization and Cardiovascular Interventions, Vol. 94, Núm. 7, pp. 917-925
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2017
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134
2014
-
Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)
Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362
2013
-
Sirolimus-eluting stent versus bare metal stent in diabetic patients: The final five-year follow-up of the DIABETES trial
EuroIntervention, Vol. 9, Núm. 3, pp. 328-335
2008
-
Long-Term Clinical Benefit of Sirolimus-Eluting Stents in Patients With In-Stent Restenosis. Results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) Study
Journal of the American College of Cardiology, Vol. 52, Núm. 20, pp. 1621-1627